HUMA

HUMA

USD

Humacyte Inc. Common Stock

$1.330+0.030 (2.308%)

リアルタイム価格

Healthcare
バイオテクノロジー
米国

価格チャート

Loading Chart...

主要指標

市場指標
企業ファンダメンタルズ
取引統計

市場指標

始値

$1.300

高値

$1.340

安値

$1.220

出来高

3.25M

企業ファンダメンタルズ

時価総額

249.1M

業種

バイオテクノロジー

United States

取引統計

平均出来高

5.40M

取引所

NMS

通貨

USD

52週レンジ

安値 $1.15現在値 $1.330高値 $6.77

関連ニュース

Analyst Upgrades

BTIG Maintains Buy on Humacyte, Lowers Price Target to $6

BTIG analyst Ryan Zimmerman maintains Humacyte with a Buy and lowers the price target from $7 to $6.

もっと見る
BTIG Maintains Buy on Humacyte, Lowers Price Target to $6
GlobeNewswire

Humacyte Announces Pricing of $60.0 Million Oversubscribed Registered Direct Offering

DURHAM, N.C., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (NASDAQ:HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today

もっと見る
Humacyte Announces Pricing of $60.0 Million Oversubscribed Registered Direct Offering
Analyst Upgrades

D. Boral Capital Maintains Buy on Humacyte, Maintains $25 Price Target

D. Boral Capital analyst Jason Kolbert maintains Humacyte with a Buy and maintains $25 price target.

もっと見る
D. Boral Capital Maintains Buy on Humacyte, Maintains $25 Price Target
GlobeNewswire

Humacyte Announces Expansion of Intellectual Property for Pipeline Products with Granting of New U.S. Patent for Bioengineered Esophagus

– Patent covers esophagus produced using Humacyte's proprietary bioengineered regenerative tissue platform, designed for implant in patients with damaged esophagus –

もっと見る
Humacyte Announces Expansion of Intellectual Property for Pipeline Products with Granting of New U.S. Patent for Bioengineered Esophagus